Precautions while taking cabozantinib

Cabozantinib (Cabozantinib) is a targeted therapy drug used to treat various types of cancer, such as advanced renal cell carcinoma and thyroid cancer. When using cabozantinib, patients need to pay close attention to some medication precautions to ensure optimal therapeutic effects and minimal adverse reactions. The following are some detailed instructions on the precautions for taking cabozantinib:

1.Physician’s Guidance: Before starting cabozantinib, patients should fully understand their physician’s prescriptions and instructions. Doctors will determine the most appropriate dosage and medication regimen based on the patient's condition, physical condition and other factors.

2.Dosage and usage: Patients must use cabozantinib exactly as prescribed by their doctor. Under normal circumstances, cabozantinib is an oral medication, 60 mg per time. It is recommended to take it at the same time and with a glass of water.

3. Diet and drinking water: While taking cabozantinib, avoid or reduce the intake of foods or drinks containing grapefruit ingredients, because grapefruit may affect the metabolism of cabozantinib and increase the concentration of the drug in the body.

4.Adverse reactions: Patients may experience some adverse reactions while using cabozantinib, including but not limited to fatigue, diarrhea, hypertension, hand-foot syndrome, proteinuria, dry mouth, etc. If any adverse reactions occur, inform your doctor immediately, who may adjust the dose or take other measures.

5.Treatment monitoring: During treatment with cabozantinib, patients need to undergo regular physical examinations and related tests to monitor the efficacy of treatment and possible adverse reactions. These tests may include blood tests, tumor marker testing, electrocardiograms, etc.

6.Drug Interactions: While taking cabozantinib, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with cabozantinib, affecting the metabolism and efficacy of the drug.

7.Pregnancy and Lactation: Cabozantinib may have adverse effects on the fetus, so patients should avoid becoming pregnant during treatment. At the same time, it is unknown whether cabozantinib is excreted in breast milk, so breastfeeding should be stopped during cabozantinib treatment.

8.Follow the doctor’s instructions: Patients must follow the doctor’s instructions while using cabozantinib and do not adjust the dosage or stop taking the medication on their own. Any dosage adjustments or changes in medication should be made under the guidance of a physician.

In general, cabozantinib is an effective cancer treatment drug, but medication precautions need to be paid close attention to during use. Patients should use drugs correctly under the guidance of a doctor and receive regular treatment monitoring to ensure the best therapeutic effect and minimize the occurrence of adverse reactions.